Henry Schein, Inc. (NASDAQ:HSIC) Stock Position Reduced by Foyston Gordon & Payne Inc

Foyston Gordon & Payne Inc reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 25.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,961 shares of the company's stock after selling 32,018 shares during the quarter. Henry Schein makes up 1.7% of Foyston Gordon & Payne Inc's portfolio, making the stock its 20th biggest holding. Foyston Gordon & Payne Inc owned approximately 0.08% of Henry Schein worth $6,571,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in HSIC. Venturi Wealth Management LLC increased its stake in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC increased its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the last quarter. City State Bank acquired a new stake in Henry Schein during the fourth quarter worth about $55,000. Finally, Allworth Financial LP increased its stake in Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company's stock worth $71,000 after acquiring an additional 609 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Jefferies Financial Group upped their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Wells Fargo & Company dropped their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Finally, Piper Sandler dropped their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $79.30.

Insider Transactions at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.08% of the company's stock.

Henry Schein Stock Up 2.7%

Shares of NASDAQ HSIC traded up $1.83 on Monday, hitting $70.47. The company had a trading volume of 1,564,636 shares, compared to its average volume of 1,635,921. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The business has a 50 day moving average of $67.57 and a two-hundred day moving average of $71.46. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.58 billion, a P/E ratio of 29.00, a PEG ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the business earned $1.10 earnings per share. The company's revenue was down .1% compared to the same quarter last year. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.